Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Febuxostat
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Febuxostat 80mg tablets
1001040V0AAAAAA
|
Febuxostat | Febuxostat | Musculoskeletal and Joint Diseases | 49,187 |
|
Febuxostat 120mg tablets
1001040V0AAABAB
|
Febuxostat | Febuxostat | Musculoskeletal and Joint Diseases | 9,467 |
|
Adenuric 80mg tablets
1001040V0BBAAAA
|
Adenuric | Febuxostat | Musculoskeletal and Joint Diseases | 995 |
|
Adenuric 120mg tablets
1001040V0BBABAB
|
Adenuric | Febuxostat | Musculoskeletal and Joint Diseases | 188 |
|
Elstabya 120mg tablets
1001040V0BCABAB
|
Elstabya | Febuxostat | Musculoskeletal and Joint Diseases | No data available |
|
Elstabya 80mg tablets
1001040V0BCAAAA
|
Elstabya | Febuxostat | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.